MODULATION BY CANINE INTERFERON-GAMMA OF MAJOR HISTOCOMPATIBILITY COMPLEX AND TUMOR-ASSOCIATED ANTIGEN EXPRESSION IN CANINE MAMMARY-TUMOR AND MELANOMA CELL-LINES
Em. Whitley et al., MODULATION BY CANINE INTERFERON-GAMMA OF MAJOR HISTOCOMPATIBILITY COMPLEX AND TUMOR-ASSOCIATED ANTIGEN EXPRESSION IN CANINE MAMMARY-TUMOR AND MELANOMA CELL-LINES, Anticancer research, 15(3), 1995, pp. 923-929
In an effort to enhance the antigenicity of canine tumor cells, canine
interferon-gamma (CnIFN-gamma) was applied in vitro to seven canine m
ammary tumor (CMT) and two canine melanoma (CML) cell lines. Surface e
xpression of major histocompatibility complex (MHC) antigens and tumor
associated antigens (TAA) was measured by a flow cytometric fluoresce
nce assay using commercially available anti-MHC antibodies, and anti-c
anine TAA monoclonal antibodies generated against CMT and CML cell lin
es. Compared to constitutive antigen levels in untreated cells, treatm
ent with CnIFN-gamma resulted in increased expression of MHC class I a
nd II antigens (up To 19-and 167-fold, respectively) and a TAA (up to
5-fold) by CMT cell lines, and increased expression of class I antigen
(131-fold) by one CML and of class II antigen (18-fold) by the other
CML cell line. Expression of MHC antigens and a TAA by tumor cells was
increased by Cn-IFN-gamma treatment, and such an increase may be of p
otential benefit in tumor cell recognition and rejection by the immune
system.